Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

12.59
Delayed Data
As of Dec 12
 -0.21 / -1.64%
Today’s Change
2.73
Today|||52-Week Range
13.35
+138.45%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close12.80
Today’s open12.97
Day’s range11.50 - 13.00
Volume20,968
Average volume (3 months)35,630
Market cap$275.7M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)-31.56%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book10.24

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.01+1.14%
STDYSteadymed Ltd-0.10-2.74%
BLRXBioLine RX Ltd-0.01-0.91%
GLMDGalmed Pharmaceutica...+0.08+0.97%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts